Five-Year Relative Survival 59.6 Percent in Lower-Risk Myelodysplastic Syndromes
Five-year overall survival 47.3 percent in patients with lower-risk myelodysplastic syndromes
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.